number of surgeries on patients age 80ϩ with CI has increased, rate per capita decreased by 14%, compared to a 20% decline in other age groups. The incidence of significant comorbidities has substantially increased; for claudicants: diabetes by 19%, HTP 30%, COPD 40%, CAD 21% and renal 230%; for patients with CI: HTP, COPD, and CAD incidence was higher (23%, 32%, 8% respectively) but diabetics decreased by 6%. Cardiac, respiratory and infection complications after amputation have increased by 29%, 28% and 10%. For LER, respiratory complications increased 9% but cardiac and infection complications actually decreased (8 and 27%) Similar trends were observed for patients with combined LER and amputation. Length of stay (LOS) declined significantly in all groups with an overall decrease of 30% (pϽ.05).
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Long Term Results of Open Versus Endovascular Revascularization of Superficial Femoral Artery Occlusive Disease: A Case Control Series
Eva M Rzucidlo 1 , Aja Bjerke 2 , Daniel Walsh 1 , Richard Powell 1 . 1 Dartmouth Hitchcock Medical Center, Lebanon, NH; 2 Dartmouth Medical School, Hanover, NH Background: For patients with superficial femoral artery (SFA) occlusive disease the most appropriate treatment has yet to be determined. We performed a case control comparison of long term results of femoral popliteal bypass and SFA endovascular interventions to examine the characteristics of patients and procedures to optimize results.
Methods:
All femoral-popliteal bypasses and SFA interventions performed for consecutive patients with symptoms Rutherford 3 to 6 between 2001 and 2008 were reviewed. Kaplan Meir survival analyses were performed to assess time-dependent outcomes. Log rank analyses, univariate and multivariate analyses were performed.
Results: During the study period 152 limbs in 141 patients (66% male, mean age 66Ϯ22 years) underwent femoral-popliteal bypass; 233 limbs in 204 patients (49% male, mean age 70 Ϯ 11 years) underwent SFA intervention. Surgery was performed less commonly for claudication (46% vs. 56%), and more commonly for critical ischemia (54% vs 44%). Six year primary, primary assisted and secondary patency rates were 56%, 64% and 75% respectively for bypass patients. Six year primary, primary assisted and secondary patency rates were 40%, 67% and 85% respectively for SFA interventions. Six years limb salvage for surgery was 80%; six year limb salvage rate was 92% for SFA interventions. Complications occurred in 21% in the surgery group and in 1.2% of the endovascular group. Re-intervention was required in 24% of surgery patients and in 14% of endovascular patients. Failure of SFA intervention led to bypass in 5% of patients, however prior failed intervention did not change target artery. Predictors of failed patency for both the surgery and SFA intervention group were female gender, diabetes, creatinine Ͼ 1.8, and critical limb ischemia. However, limb salvage was no different for all groups.
Conclusions: Though long term patency and limb salvage were equivalent in this case controlled study of femoral popliteal bypass versus SFA interventions, re-inventions and complications occurred at a higher rate in the surgery group. Women, diabetics and renal failure patients had sustained patency less frequently with both treatments; however, limb salvage was not disadvantaged for any group. SFA stent placement should therefore be initial therapy for patients with SFA occlusive disease. PP42.
Blood Transfusion is Associated With Increased Morbidity and Mortality After Lower Extremity Revascularization
Eleftherios S Xenos 1,2 , Daniel Davenport 1 , Nick Abedi 1 , David J Minion 1,2 , Ehab Sorial 1 , Shane O'Keeffe 1 , Eric D Endean 1,2 . 1 University of Kentucky Medical Center, Lexington, KY; 2 VA Medical Center, Lexington, KY Background: In adult ICU, trauma, and surgical patients, blood transfusion is associated with increased morbidity and mortality as well as increased risk of venous /arterial thrombotic events and mortality in hospitalized cancer patients. We analyzed data from the NSQIP database to examine the effect of intraoperative blood transfusion in patients undergoing lower extremity revascularization( LER).
Methods: We queried the ACS NSQIP database from 2005 to 2007. CPT codes were used to identify LER procedures which were grouped into thromboendarterectomy(TEA), bypass with vein(BV) or prosthetic graft (BP). Multivariable analysis adjusted transfusion impact for clinical risk factors, procedure group and complexity.
Results: Our query resulted in 8799 patients, 66.8 Ϯ 12.0 years of age, of whom 5569 (63.3%) were male. 12% underwent TEA, 42% underwent BP and 46% underwent BV. Composite mortality was 2.9%, morbidity 25.5%. Transfusion rates varied across procedure group from 14.5% in TEA patients, 20.1% in BV patients, to 27.1% in BP patients. Intraoperative transfusion was associated with increased morbidity and mortality; after adjustment for clinical risk factors, procedure type and complexity, transfusion remained significantly predictive of poorer outcomes: 
